• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Miss Universe contestants walk out of event in protest

admin - Latest News - November 6, 2025
admin
19 views 6 secs 0 Comments



Miss Universe contestants walk out of event in protest



Source link

TAGS:
PREVIOUS
Supreme Court questions Trump’s authority on tariffs
NEXT
Death toll rises to 12 in UPS plane crash in Kentucky
Related Post
September 26, 2025
Sept. 26, 2025, 11:24 AM EDTBy Rob Wile and Steve KopackAnalysts are already warning that U.S. consumers could see higher prices due to new tariffs President Donald Trump plans to impose on drug product imports as soon as next week.But a series of exemptions may blunt the ultimate impact. In a Truth Social post late Thursday, Trump said that any branded or patented pharmaceutical products brought into the U.S. would face a 100% tariff starting Oct. 1.U.S. imports of pharmaceuticals totaled about $213 billion in 2024, a threefold increase from a decade earlier, according to data from the United Nations Comtrade Database.With Asia alone accounting for just over 20% of those imports by value, U.S. consumers could see a “meaningful commercial hit,” Louise Loo, head of Asia economics at Oxford Economics research group, said in a note to clients. Previous studies have shown that U.S. annual spending per capita on prescription drugs is about double the rest of the developed world. In July, Trump announced a plan to “get Americans the best prices in the world for prescription drugs” that involved asking major drugmakers to match low prices they offer elsewhere in the world. However, it is not clear what actions the pharma firms have taken to begin addressing that demand. The pharmaceutical industry is already warning that the new tariffs could derail further drug development while also raising prices. “Every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures,” Alex Schriver, senior vice president for PhRMA, the drug industry’s primary lobbying group, said in a statement. “Medicines have historically been exempt from tariffs because they raise costs and could lead to shortages.”Despite those warnings, a significant share of drug products could wind up being exempted from the new import duties. The tariffs do not appear to apply to so-called generic drugs, which account for 9 out of 10 prescriptions filled in the U.S., according to the Food and Drug Administration. The White House did not immediately respond to a request to confirm the exemption for generics, but assuming they will remain tariff-free, the impact to consumers could be more limited than feared. Trump also specified that any drug companies that currently have, or have committed to building, U.S.-based drug-making facilities would be exempted from tariffs. That’s a category that includes numerous major drugmakers. “Many pharmaceutical companies have facilities in the U.S., so it may be relatively easy to superficially expand those facilities to avoid tariffs being applied,” Paul Donovan, chief global economist at UBS Global Wealth Management, wrote in a note to clients. Analysts at JPMorgan agreed: “While there remains very limited details, we note that this will likely lead to a majority of pharma products being excluded from any tariffs” because most major companies have recently increased or have started to increase their U.S. manufacturing facilities.On the White House website, the administration maintains a “running list of new U.S. investment” from private companies. At least 15 pharmaceutical or drug makers are listed with investments ranging from new manufacturing facilities, tens of billions in expanded U.S. production and increased R&D spending. Many of those announcements would appear to meet the requirements laid out by Trump to avoid the new tariff.Two major European drugmakers, Roche and Novartis, said in statements that they expected little to no impact from the newly announced duties. “We are working to ensure that all major Novartis medicines for U.S. patients are manufactured in the U.S.,” Novartis said in a statement. “The announced 100% tariff should not have an impact.” Roche pointed to ongoing factory construction in the U.S., with multiple sites being expanded and upgraded in Kentucky, Indiana, New Jersey and California.Trump has signaled since at least April that drug imports would face tariffs. In anticipation, major drugmakers have indicated they have been stockpiling supplies, analysts said. As a result, consumers are unlikely to feel immediate effects even though the tariffs are set to kick in next week. “We think there may have been significant inventory accumulation this year,” Neil Shearing, group chief economist with Capital Economics, said in a note. This summer, Trump placed a maximum 15% tariff on most pharmaceuticals coming in from the European Union, which accounts for 60% of drugs imported by the U.S. E.U. officials believe that this agreement will shield it from the 100% duties, though they said they could not be certain. “This clear all-inclusive 15% tariff ceiling for E.U. exports represents an insurance policy that no higher tariffs will emerge for European economic operators,” a European Commission spokesperson told NBC News on Friday.Ireland’s deputy prime minister, Simon Harris, who also acts as trade minister, said his country is “studying the impact of this announcement” but added that he believed the 15% cap on pharma tariffs remained in place. Ireland alone accounts for 24% of pharma imports to the U.S.Rob WileRob Wile is a Pulitzer Prize-winning journalist covering breaking business stories for NBCNews.com.Steve KopackSteve Kopack is a senior reporter at NBC News covering business and the economy.
November 24, 2025
Maduro dances to 'no war, yes peace' speech remix
November 24, 2025
Nov. 23, 2025, 10:33 AM EST / Updated Nov. 23, 2025, 12:09 PM ESTBy Alexandra MarquezTreasury Secretary Scott Bessent on Sunday said “no” when asked whether the U.S. was at risk of entering a recession in 2026, telling NBC News’ “Meet the Press” he’s confident Americans will feel economic relief next year stemming from President Donald Trump’s tariff agenda and trade deals.“I am very, very optimistic on 2026. We have set the table for a very strong, noninflationary growth economy,” Bessent told moderator Kristen Welker.He also said, “We believe health care is going to come down,” adding that the Trump administration would have news on that front this week.Bessent says inflation ‘has nothing to do with tariffs’ as U.S. rolls them back: Full interview12:52The treasury secretary acknowledged that there is some pressure on the economy in certain sectors like housing, responding to comments from National Economic Council Director Kevin Hassett earlier this month that “we’re starting to see pockets of the economy that look like they might be in a recession.”“Clearly, housing has been struggling, and interest rate-sensitive sectors have been in a recession,” Bessent said Sunday. He added that the recent government shutdown, which was the longest in history, also squeezed the economy.An NBC News poll earlier this month found that about two-thirds of registered voters say the Trump administration has fallen short on the economy and the cost of living.Still, the treasury secretary pointed to the GOP’s landmark domestic policy package that Trump signed into law over the summer — the president’s “big, beautiful bill” — and to the Trump’s tariff and trade agenda as signs that 2026 will yield a stronger economy for Americans.“I am very confident about 2026, because what we are going to see is the president has done peace deals, tax deals and trade deals [and] the ‘One Big, Beautiful Bill,’” Bessent said, adding that the various components of that legislation are “all kicking in.”In a separate interview on Fox, Hassett also predicted that “it’s going to be an absolute blockbuster year ahead.””The good news for the next year is that the factories are going to be in place, and then people are going to start getting the jobs next to the machines and everything else. And so it really, really is a very, very promising set of data,” he added.Also Sunday, the treasury secretary published an opinion piece in The Washington Post calling for an end to the Senate filibuster.“It’s time for Republicans to acknowledge that the filibuster no longer serves the country — and to be prepared to end it,” he wrote in the piece, later telling Welker that it was meant “to put the Senate on notice.”“The Democrats haven’t been able to stop President Trump in the courts. They haven’t been able to stop him in the media, so they had to harm the American people — 1.5% hit to GDP,” Bessent said, referencing the recent shutdown. “They don’t care. So I believe that Senate Democrats — if Senate Democrats close the government again, that Senate Republicans should immediately abrogate the filibuster.”Bessent also blasted several Democratic lawmakers who are former military and intelligence officers after they released a video telling current military and intelligence officers that they “must refuse” any illegal orders given by the Trump administration.“What I am confident of is that this was a display of gross, gross negligence,” he said, not answering a question about whether the Trump administration is issuing illegal orders.He added, “There is one commander in chief, and when you step outside of the chain of command and try to create the noise and chaos, that only helps our enemies.”He also spoke about the ongoing peace negotiations between Russia and Ukraine, voicing support for a 28-point peace deal backed by the U.S. that has drawn concern from Ukrainians, European leaders and a bipartisan group of senators who say the peace proposal favors Russia.“At the end of the day, it’s going to be a decision with the Ukrainians. President Trump is a president of peace,” Bessent said before blasting European leaders who are planning more sanctions on Russia.“The Europeans tell me, ‘Oh, we are doing our 19th sanctions package.’ In my mind … if you’re going to do something 19 times, you failed,” the treasury secretary said, instead praising Trump’s economic sanctions package on India, which targeted Russian oil.He added that he has not spoken to the president about an alleged timeline for negotiating this peace proposal, including whether Trump is pushing for the deal to be signed by Thanksgiving.Alexandra MarquezAlexandra Marquez is a politics reporter for NBC News.Megan Shannon contributed.
November 28, 2025
Black Friday deals are here — I handpicked the 133+ best ones from Amazon, Apple and more
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved